
FHD-286
CAS No. 2671128-05-3
FHD-286( —— )
Catalog No. M28880 CAS No. 2671128-05-3
FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 335 | Get Quote |
![]() ![]() |
10MG | 520 | Get Quote |
![]() ![]() |
25MG | 840 | Get Quote |
![]() ![]() |
50MG | 1143 | Get Quote |
![]() ![]() |
100MG | 1521 | Get Quote |
![]() ![]() |
500MG | 3087 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameFHD-286
-
NoteResearch use only, not for human use.
-
Brief DescriptionFHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.
-
DescriptionFHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.
-
In Vitro——
-
In VivoAnimal Model:B16F10 tumor-bearing miceDosage:1.5 mg/kg Administration:Oral administration; for 10 days Result:Increased in IFNγ and Th1-type chemokine CXCL10 levels.
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2671128-05-3
-
Formula Weight562.66
-
Molecular FormulaC24H30N6O6S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (444.32 mM)
-
SMILESC[C@H](C1)O[C@@H](C)CN1c1cccc(-c2csc(NC([C@H](COC)NC(c(cc3)cn3S(C)(=O)=O)=O)=O)n2)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Qiao J, et al. Identification of a Novel Specific Cucurbitadienol Synthase Allele in Siraitia grosvenorii Correlates with High Catalytic Efficiency. Molecules. 2019 Feb 11;24(3).
molnova catalog



related products
-
JQAD1
JQAD1 is a potent and selective histone acetyltransferase EP300 degrader (PROTAC?; DC50≤ 31.6 nM); comprises an EP300 inhibitor, A485, joined by a linker to a cereblon E3 ligase ligand.
-
dCBP-1
dCBP-1 is a chemical degrader of p300/CBP. dCBP-1 hijacks the E3 ubiquitin ligase CRBN for selective degradation of p300/CBP. Degradation of p300/CBP by dCBP-1 leads to effective multiple myeloma cell killing.
-
UNC926 hydrochloride
UNC926 hydrochloride is a?methyl-lysine (Kme) reader domain?inhibitor.